Anti-neutrophil Cytoplasmic Antibodies in Primary Small Vessel Vasculitides

References

• Davies D, Moran M E, Niall J F, Ryan G B. Segmental glomerulonephritis with antineutrophil antibody: possible arbovirus aetiology. Br J Med 1982; 285: 606
   PubMed Web of Science ®Google Scholar
• Hall J B, Wadham B, Wood C D, Ashton V, Adam W R. Vasculitis and glomerulonephritis: A subgroup with antineutrophil cytoplasmic antibody. Aust NZ J Med 1984; 14: 277–8
   PubMedGoogle Scholar
• Jennette J C, Falk R J. Antineutrophil cytoplasmic autoantibodies and associated diseases: A review. Am J Kidney Dis 1990; 15: 517–29
   PubMed Web of Science ®Google Scholar
• Kallenberg C GM, Cohen Tervaert J W, van der Woude F J, Goldschmeding R, von dem Borne A EGK, Weening J J. Autoimmunity to lysosomal enzymes: new clues to vasculitis and glomerulonephritis. Immunol Today 1991; 12: 61–4
   PubMedGoogle Scholar
• Wegener F. Über eine eigenartige rhinogene granulomatose mit besonderer beteiligung des arteriensystems und der nieren. Beitr Pathol 1939; 102: 36–68
   Google Scholar
• Rasmussen N, Wiik A. (1985) Autoimmunity in Wegener's granulomatosis Immunology, Autoimmunity and Transplantation in Otolaryngology. Proceedings of the First International Academic Conference in Immunology and Immunopathology as applied to Otology and Rhinology. 1985, J E Veldman, J E McCabe, E H Huizing, N Mygind. Kugler Publications, Utrecht, 231–6
   Google Scholar
• van der Woude F J, Rasmussen N, Lobatto S, Wiik A, Permin H, van Es L A. Autoantibodies against neutrophils and monocytes: Tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet 1985; i: 425–9
   Google Scholar
• Nölle B, Specks U, Lüdemann J, Rohrbach M S, Deremee R A, Gross W L. Anticytoplasmic antibodies: their immunodiag-nostic value in Wegener's granulomatosis. Ann Intern Med 1989; 111: 28–40
   PubMed Web of Science ®Google Scholar
• Savage C OS, Winearls C G, Jones S, Marshall P D, Lockwood C M. Prospective study of radioimmunoassay for antibodies against neutrophil cytoplasm in diagnosis of systemic vasculitis. Lancet 1987; i: 1389–93
   Google Scholar
• Gross W L, Schmitt W H, Csernok E. ANCA and associated diseases: immunodiagnostic and pathogenetic aspects. Clin Exp Immunol 1993; 91: 1–12
   PubMed Web of Science ®Google Scholar
• Jennette J C, Falk R J, Andrassy K, Bacon P A, Churg J, Gross W L, et al. Nomenclature of systemic vasculitides: the proposal of an international consensus conference. Arthritis Rheum 1994; 37: 187–92
   PubMed Web of Science ®Google Scholar
• Masi A T, Hunder G G, Lie J T, Michel B A, Bloch D A, Arend W P, et al. The American College of Rheumatology 1990 Criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum 1990; 33: 1094–100
   PubMed Web of Science ®Google Scholar
• Leavitt R Y, Fauci A S, Bloch D A, Michel B A, Hunder G G, Arend W P, et al. The American College of Rheumatology 1990 Criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 1990; 33: 1101–7
   PubMed Web of Science ®Google Scholar
• Savage C OS, Winearls C G, Evand D J, Rees A J, Lockwood C M. Microscopic polyarteritis: presentation, pathology and prognosis. Q J Med 1985; 56: 467–83
   PubMedGoogle Scholar
• Wiik A. Delineation of a standard procedure for indirect immunofluorescence detection of ANCA. APMIS 1989; 97(Suppl 6)12–3
   Google Scholar
• Wiik A, van der Woude F J. The new ACPA/ANCA nomenclature. Neth J Med 1990; 36: 107–8
   PubMed Web of Science ®Google Scholar
• Wiik A, Rasmussen N, Wieslander J. Methods to detect autoantibodies to neutrophilic granulocytes. Manual of Biological Markers of Disease, W I van Venrooij, R N Maini. Kluwer Academic Publishers, The Netherlands 1993; 1–14
   Google Scholar
• Falk R J, Terrell R S, Charles L A, Jennette J C. Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci USA 1990; 87: 4115–9
   PubMed Web of Science ®Google Scholar
• Savage C OS, Pottinger B E, Gaskin G, Pusey C D, Pearson J D. Autoantibodies developing to myeloperoxidase and proteinase 3 in systemic vasculitis stimulate neutrophil cytotoxicity toward cultured endothelial cells. Am J Pathol 1992; 141: 335–42
   PubMed Web of Science ®Google Scholar
• Wiik A. Antineutrophil cytoplasmic antibodies in Wegener's granulomatosis. Clin Exp Rheumatol 1993; 11: 191–201
   PubMed Web of Science ®Google Scholar
• van der Woude F J, Daha M R, van Es L A. The current status of neutrophil cytoplasmic antibodies. Clin Exp Immunol 1989; 78: 143–9
   PubMed Web of Science ®Google Scholar
• Esnault V LM, Solimani B, Keogan M T, Brownlee A A, Jayne D RW, Lockwood C M. Association of IgM with IgG ANCA in patients presenting with pulmonary hemorrhage. Kidney Int 1992; 41: 1304–10
   PubMed Web of Science ®Google Scholar
• Cohen Tervaert J W, van der Woude F J, Fauci A S, Ambrus J L, Velosa J, Keane W F, et al. Association between active Wegener's granulomatosis and anticytoplasmic antibodies. Arch Intern Med 1989; 149: 2461–5
   PubMedGoogle Scholar
• Jayne D RW, Gaskin G, Pusey C D, Lockwood C M. ANCA and predicting relapse in systemic vasculitis. Q J Med 1995; 88: 127–33
   Google Scholar
• Cohen Tervaert J W, Mulder A HL, Kallenberg C GM, Stegeman C A. Measurement of IgG3 levels of anti-proteinase antibodies is useful in monitoring disease activity in Wegener's granulomatosis. J Am Soc Nephrol 1994; 5: 828, Abstract
   Google Scholar
• Jayne D RW, Lockwood C M. Pooled immunoglobulin in the management of systemic vasculitis. Proceedings of the Fourth International Workshop on ANCA, Lübeck, 1992, Abstract
   Google Scholar
• Rossi F, Jayne D RW, Lockwood C M, Kazatchkine M D. Anti-idiotypes against antineutrophil cytoplasmic antigen autoantibodies in normal human polyspecific IgG for therapeutic use and in the remission sera of patients with systemic vasculitis. Clin Exp Immunol 1991; 83: 298–303
   PubMed Web of Science ®Google Scholar
• Nassberger L, Sjöholm A G, Jonsson H, Sturfelt G, Åkesson A. Autoantibodies against neutrophil cytoplasmic compounds in systemic lupus erythematosus and in hydralazine-induced lupus. Clin Exp Immunol 1990; 81: 380–3
   PubMed Web of Science ®Google Scholar
• Kallenberg C GM, Brouwer E, Weening J J, Cohen Tervaert J W. Anti-neutrophil cytoplasmic antibodies: current diagnostic and pathophysiological potential. Kidney Int 1994; 46: 1–15
   PubMed Web of Science ®Google Scholar
• Zhao M H, Jones S J, Lockwood C M. Bactericidal/permeability-increasing protein (BPI) is an important antigen for antineutrophil cytoplasmic autoantibodies (ANCA) in vasculitis. Clin Exp Immunol 1995; 99: 49–56
   PubMed Web of Science ®Google Scholar
• Falk R F, Becker M, Terrell R, Jennette J C. Antigen specificity of p-ANCA and of c-ANCA. Am J Kidney Dis 1915; 18: 197, Abstract
   Google Scholar
• Hagen E C, Andrassy K, Csernok E, Daha M R, Gaskin G, Gross W, et al. The value of indirect immuno-fluorescence and solid phase techniques for ANCA detection. A report on the first phase of an International cooperative study on the standardization of ANCA assays. J Immunol Methods 1993; 159: 1–16
   PubMed Web of Science ®Google Scholar
• Rasmussen N, Wiik A, Hoier-Madsen M, Pedersen K, Baslund B, Wieslander J. c-ANCA in Denmark, 1990. A complete consecutive series. Proceedings of the Fourth International Workshop on ANCA, Liibeck, 1992, Abstract
   Google Scholar
• Andrews M, Edmunds M, Campbell A, Walls J, Feehally J. Systemic vasculitis in the 1980s - Is there an increasing incidence of Wegener's granulomatosis and microscopic polyarteritis. J R Coll Physicians Lond 1990; 24: 284–8
   PubMedGoogle Scholar
• Stegeman C A, Cohen Tervaert J W, Sluiter W J, Manson W L, de Jong P E, Kallenberg C GM. Association of chronic nasal carriage of Staphylococcus aureus and higher relapse rates in Wegener's granulomatosis. Ann Intern Med 1994; 120: 12–17
   PubMed Web of Science ®Google Scholar